Trauma reactivation plus propranolol is associated with durably low physiological responding during subsequent...

Area of Science:

• Psychiatry
• Neuroscience
• Psychophysiology

Background:

• Previous research indicated propranolol reduced physiological responses in PTSD patients one week post-treatment.
• The current study aimed to determine if this effect is durable using a modified approach.

Purpose of the Study:

• To investigate the extended durability of propranolol's effect on physiological responses in PTSD patients.
• To assess if a modified trauma reactivation plus propranolol treatment maintains efficacy beyond one week.

Main Methods:

• Twenty-eight PTSD participants underwent weekly trauma script exposure with open-label propranolol for six weeks.
• Physiological responses (skin conductance, heart rate, electromyogram) were measured during traumatic imagery at one week and four months post-treatment.
• Results were compared to a prior placebo-controlled study.

Main Results:

• Most participants no longer met PTSD criteria post-treatment and at follow-up.
• Propranolol-treated participants showed significantly lower post-treatment physiological responses compared to previous placebo group.
• No significant difference in physiological responding was found between posttreatment and four-month follow-up.

Conclusions:

• The reduction in physiological responding during traumatic imagery persists for at least four months.
• The findings suggest trauma reactivation with propranolol may be a durable and effective PTSD treatment.
• Further trials are warranted to confirm clinical efficacy, despite limitations like the absence of a placebo group.